Publications by authors named "Forat Lutfi"

Claim this Profile
I
Immune Effector Cell-Associated HLH-Like Syndrome (IEC-HS) in CAR-T and TCE-Treated Myeloma and B-Cell Malignancies: Insights from a Pharmacovigilance Study.
Sohaib Irfan, Fathima Shehnaz Ayoobkhan, Nikhil Vojjala, Raabia Qureshi, Raeef Rahman, Forat Lutfi

Transplant Cell Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Sponsors on Development of Clinical Research in Multiple Myeloma and AL Amyloidosis: An In-Depth Analysis.
Anas Zayad, Nausheen Ahmed, Zahra Mahmoudjafari, Barry S Skikne, Tara Lin, Forat Lutfi

Clin Lymphoma Myeloma Leuk· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous Transplant or CAR-T as Consolidation Options in MYC Rearranged Large B-Cell Lymphoma Patients in Remission After Salvage Treatments.
Fateeha Furqan, Kwang W Ahn, Manmeet Kaur, Jinalben Patel, Stephen Ansell, Forat Lutfi

Am J Hematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19 CAR-T With Axicabtagene Ciloleucel in R/R Large B-Cell Lymphoma With/Without Prior Autologous Stem Cell Transplant.
David T Chen, Olga Goloubeva, Aaron P Rapoport, Saurabh Dahiya, Djordje Atanackovic, Forat Lutfi

Clin Lymphoma Myeloma Leuk· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen receptor T cell therapy in octogenarians with B cell lymphoma: a real-world US multicenter collaborative study.
Mohamed A Kharfan-Dabaja, Razan Mohty, Neela Easwar, Patrick Johnston, Madiha Iqbal, Forat Lutfi

Bone Marrow Transplant· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission of Chimeric Antigen Receptor T-Cell-Refractory Diffuse Large B-Cell Lymphoma Resolved by Surgery and CD20 Bispecific Therapy.
Vinny Lococo, Luke Selby, Rebecca Farmer, Janet Woodroof, Marc Hoffmann, Forat Lutfi

Cureus· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete Remission of Plasmablastic Lymphoma With Daratumumab and a Mild Regimen of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone (Mini-CHOP).
Samuel Z Davis, Wei Cui, Jordan Snyder, Forat Lutfi

Cureus· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with chimeric antigen receptor T-cell therapy in Rheumatological disorders: A systematic review.
Fizza Zulfiqar, Moazzam Shahzad, Muhammad Kashif Amin, Abhinav Vyas, Zouina Sarfraz, Forat Lutfi

Transpl Immunol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The current socioeconomic and regulatory landscape of immune effector cell therapies.
Chiranjeevi Sainatham, Devvrat Yadav, Aravind Dilli Babu, Jayanth Reddy Tallapalli, Sai Gautham Kanagala, Forat Lutfi

Front Med (Lausanne)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The emergence of bispecific T-cell engagers in the treatment of follicular and large B-cell lymphomas.
Forat G Lutfi, Nausheen Ahmed, Marc S Hoffmann, Aung Tun, Joseph P McGuirk

Clin Adv Hematol Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel.
Nausheen Ahmed, William Wesson, Forat Lutfi, David L Porter, Veronika Bachanova

Blood Adv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Secondary Hemophagocytic Lymphohistiocytosis Associated With Diffuse Large B-cell Lymphoma Using Loncastuximab Tesirine As Lymphoma-Directed Therapy.
Timothy Schieber, Jordan Snyder, Forat Lutfi

Cureus· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: Insights from a real-world experience.
Matthew McGuirk, Moazzam Shahzad, Muhammad Kashif Amin, Muhammad Atif Khan, Polina Bellman, Forat Lutfi

Transpl Immunol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world CAR-T findings for large B-cell lymphoma from a single institution experience.
Forat Lutfi, Aung M Tun, Marc Hoffmann, Nausheen Ahmed

Ann Palliat Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation.
Muhammad Umair Mushtaq, Moazzam Shahzad, Muhammad K Amin, Forat Lutfi, Shaun DeJarnette

Leuk Lymphoma· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation.
Joe S Al-Ramahi, Moazzam Shahzad, Andrea Nguyen, Kevin Li, Muhammad Kashif Amin, Forat Lutfi

Bone Marrow Transplant· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons learned from COVID-19 pandemic: outcomes after SARS-CoV-2 infection in hematopoietic cell transplant and cell therapy recipients.
Joe S Al-Ramahi, Moazzam Shahzad, Kevin Li, Shaun DeJarnette, Sibgha Gull Chaudhary, Forat Lutfi

Leuk Lymphoma· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the High-Grade and Refractory Neurotoxicity of Teclistamab: An Underreported Entity.
Forat Lutfi, Al-Ola Abdallah, Muhammad Nashatizadeh, Nausheen Ahmed, Maggie Nelson

Cureus· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by F-FDG PET/CT Imaging Following CAR-T Therapy.
Forat Lutfi, Olga Goloubeva, Amer Kowatli, Anton Gryaznov, Dong W Kim

Clin Lymphoma Myeloma Leuk· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and review.
Aisha A Mumtaz, Andrew Fischer, Forat Lutfi, Lisa R Matsumoto, Djordje Atanackovic

Br J Ophthalmol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis.
Moazzam Shahzad, Andrea Nguyen, Ali Hussain, Mohammad Ammad-Ud-Din, Muhammad Salman Faisal, Forat Lutfi

Front Immunol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line treatment with CAR T-cell therapy for large B-cell lymphoma.
Forat Lutfi, Ameet Patel, Jasmine Mehta, Anmol Goyal, Saurabh Dahiya

Clin Adv Hematol Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic review.
Moazzam Shahzad, Sibgha Gull Chaudhary, Ezza Tariq, Ali Hassan Mushtaq, Iqra Anwar, Forat Lutfi

Leuk Lymphoma· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience.
Hanan Alkhaldi, Olga Goloubeva, Aaron P Rapoport, Saurabh Dahiya, Yifan Pang, Forat Lutfi

Transplant Proc· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapy.
Djordje Atanackovic, Tim Luetkens, Destiny Omili, Thierry Iraguha, Forat Lutfi

Blood· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis